Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 210, Issue 4, Pages 517-534
Publisher
Oxford University Press (OUP)
Online
2014-03-09
DOI
10.1093/infdis/jiu139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Determinants of seropositivity among HPV-16/18 DNA positive young women
- (2016) Carolina Porras et al. BMC INFECTIOUS DISEASES
- Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial
- (2013) M. Safaeian et al. Cancer Prevention Research
- Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women
- (2013) Yan Tong et al. JOURNAL OF MEDICAL VIROLOGY
- Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naive Women in HPV Vaccine Trials
- (2012) M. Safaeian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial
- (2012) Edith Roset Bahmanyar et al. GYNECOLOGIC ONCOLOGY
- Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine
- (2012) Cecilia M. Roteli-Martins et al. Human Vaccines & Immunotherapeutics
- Correlation between direct ELISA, single epitope-based inhibition ELISA and Pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine
- (2011) Francis J. Dessy et al. Human vaccines & immunotherapeutics
- A Competitive Serological Assay Shows Naturally Acquired Immunity to Human Papillomavirus Infections in the Guanacaste Natural History Study
- (2011) Nicolas Wentzensen et al. JOURNAL OF INFECTIOUS DISEASES
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young Women
- (2010) R. P. Insinga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
- (2010) Sven-Eric Olsson et al. Human vaccines & immunotherapeutics
- Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33
- (2010) Marko Merikukka et al. INTERNATIONAL JOURNAL OF CANCER
- Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
- (2010) M. Safaeian et al. JNCI-Journal of the National Cancer Institute
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes
- (2010) Johanna Palmroth et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Seroprevalence and Correlates of Human Papillomavirus 16/18 Seropositivity Among Young Women in Costa Rica
- (2010) Sarah Coseo et al. SEXUALLY TRANSMITTED DISEASES
- Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine Trials
- (2009) John T. Schiller et al. JOURNAL OF INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started